Diffuse large B-cell lymphoma: open trials in United States
132 open trials have a site in United States. Registry data; only the trial team decides who can take part.
NCT03223610
Venetoclax, Ibrutinib, Prednisone, Obinutuzumab, and Revlimid (ViPOR) in Relapsed/Refractory B-cell Lymphoma
Trial Treatment · Phase 1/2 · National Cancer Institute (NCI)
National Institutes of Health Clinical Center, Bethesda
Registry updated 2026-11-05
NCT07649304
AMC 120, Glofitamab Plus Chemoimmunotherapy in Newly Diagnosed HIV-Associated Large B-Cell Lymphoma (The "Glofit-RCHOP Study")
Trial Treatment · Phase 1 · National Cancer Institute (NCI)
AIDS Malignancy Consortium, Rockville
Registry updated 2026-11-05
NCT03125642
Auto Stem Cell Transplant for Lymphoma Patients
Trial Treatment · Phase 2 · Masonic Cancer Center, University of Minnesota
Masonic Cancer Center, University of Minnesota, Minneapolis
Registry updated 2026-11-04
NCT06091865
A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
Trial Treatment · Phase 3 · Regeneron Pharmaceuticals
University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore · Beth Israel Deaconess Medical Center, Boston · University Hospitals Cleveland Medical Center*, Cleveland · Henry Ford Health System, Detroit · Duke University Medical Center, Durham · Cancer and Hematology Centers of Western Michigan, Grand Rapids · East Carolina University, Greenville · Center for Oncology and Blood Disorders, Houston · St Vincent Ascension at Peyton Manning Childrens Hospital, Indianapolis · Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis · Mayo Clinic- Jacksonville, Jacksonville · University of Kentucky, Lexington · David Geffen School of Medicine at UCLA, Los Angeles · Rutgers Cancer Institute of New Jersey, New Brunswick · Investigative Clinical Research of Indiana, Noblesville · Community Cancer Trials of Utah, Ogden · University of California Irvine Medical Center, Orange · Mayo Clinic - Rochester, Rochester · UC Davis Comprehensive Cancer Center, Sacramento · Mayo Clinic - Arizona, Scottsdale · Stony Brook University Hospital, Stony Brook · ProHealth Care Inc, Waukesha · Clinical Research Alliance Inc, Westbury
Registry updated 2026-11-04
NCT07188558
A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
Trial Treatment · Phase 3 · Lyell Immunopharma, Inc.
University of New Mexico Comprehensive Cancer Center, Albuquerque · Northside Hospital, Atlanta · University of Colorado, Aurora · St. David's South Austin Medical Center, Austin · Tufts Medical Center, Boston · Roswell Park Comprehensive Cancer Center, Buffalo · Northwestern, Chicago · University of Chicago, Chicago · Oncology Hematology Care Clinical Trials, Cincinnati · University of Cincinnati, Cincinnati · Cleveland Clinical Taussig Cancer Center, Cleveland · Colorado Blood Cancer Institute, Denver · Duke Cancer Institute, Durham · University of Texas Southwestern Medical Center, Fort Worth · Banner MD Anderson Cancer Center, Gilbert · Hackensack, Hackensack · MD Anderson Cancer Center, Houston · University of Iowa, Iowa City · Mayo Clinic Florida, Jacksonville · University of Arkansas, Little Rock · Cedars-Sinai Medical Center, Los Angeles · University of California Los Angeles (UCLA)., Los Angeles · University of Louisville Health, Louisville · Medical College of Wisconsin, Milwaukee · Atlantic Health, Morristown · SCRI Oncology Partners, Nashville · Virginia Oncology Associates, Norfolk · University of Nebraska Medical Center (UNMC), Omaha · University of California Irvine, Orange · AdventHealth, Orlando · Allegheny Health Network, Pittsburgh · Virginia Commonwealth University/Massey Cancer Center, Richmond · Mayo Clinic - Rochester, Rochester · Intermountain Healthcare, Salt Lake City · Texas Transplant Institute, San Antonio · Mayo Clinic - Arizona, Scottsdale · Honor Health, Scottsdale · Moffitt Cancer Center, Tampa · MedStar Georgetown University Hospital, Washington D.C. · University of Kansas Cancer Center, Westwood · Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Winston-Salem
Registry updated 2026-11-04
NCT07226843
A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
Trial Treatment · Phase 1 · Eli Lilly and Company
Emory University Hospital, Atlanta · Massachusetts General Hospital, Boston · Dana-Farber Cancer Institute, Boston · The Ohio State University (OSU), Columbus · Texas Oncology - DFW (Sammons CC), Dallas · Colorado Blood Cancer Institute, Denver · City of Hope, Duarte · Baylor College of Medicine, Houston · University of California, Los Angeles (UCLA) - Medical Center, Los Angeles · University of Miami - Sylvester Cancer Center, Miami · Froedtert Hospital and the Medical College of Wisconsin, Milwaukee · Vanderbilt University Medical Center, Nashville · Sarah Cannon Research Institute, Nashville · Columbia University, New York · Oregon Health & Science University (OHSU), Portland · Mayo Clinic - Rochester, Rochester · University of Rochester, Rochester · University of California San Francisco (UCSF) - Helen Diller Family Comprehensive Cancer Center, San Francisco · Florida Cancer Specialists - Sarasota, Sarasota · Mayo Clinic Scottsdale, Scottsdale · University of Washington - Fred Hutchinson Cancer Center (Seattle Cancer Care Alliance), Seattle
Registry updated 2026-11-04
NCT05139017
A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
Trial Treatment · Phase 2/3 · Merck Sharp & Dohme LLC
University of Maryland ( Site 0123), Baltimore · Beverly Hills Cancer Center ( Site 0184), Beverly Hills · St. Vincent Frontier Cancer Center-Research ( Site 0108), Billings · Boca Raton Regional Hospital- Lynn Cancer Institute ( Site 0163), Boca Raton · Dana-Farber Cancer Institute-Lymphoma ( Site 0111), Boston · Clermont Oncology Center ( Site 0174), Clermont · Saint Elizabeth Medical Center Edgewood ( Site 0165), Edgewood · Palo Verde Hematology/ Oncology Center, Ltd. ( Site 0175), Glendale · Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0188), Grand Island · Corewell Health ( Site 0162), Grand Rapids · BRP-Hialeah Hospital ( Site 0182), Hialeah · Alliance Cancer Specialists (ACS) ( Site 8001), Horsham · Tennessee Cancer Specialists ( Site 7000), Knoxville · Comprehensive Cancer Centers of Nevada ( Site 0168), Las Vegas · University of Kentucky Chandler Medical Center ( Site 0158), Lexington · Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0133), Louisville · Atlantic Health System ( Site 0116), Morristown · Vanderbilt University Medical Center-Vanderbilt-Ingram Cancer Center ( Site 0156), Nashville · Illinois Cancer Specialists ( Site 8000), Niles · Oncology Hematology West, PC dba Nebraska Cancer Specialists ( Site 0177), Omaha · Presbyterian Rust Jorgensen Cancer ( Site 9506), Rio Rancho · Blue Ridge Cancer Care ( Site 0169), Roanoke · New York Medical College ( Site 0113), Valhalla · Bass Medical Group ( Site 0166), Walnut Creek · Innovative Clinical Research Institute ( Site 0122), Whittier · University of Massachusetts Medical School ( Site 0119), Worcester
Registry updated 2026-11-03
NCT05365659
IKS03 in Patients With Advanced B Cell Non-Hodgkin Lymphomas
Trial Treatment · Phase 1 · Iksuda Therapeutics Ltd.
University of Maryland, Baltimore, Baltimore
Registry updated 2026-11-03
NCT06323447
Pivotal Study to Validate a Novel System to Non-Invasively Detect Severe Neutropenia
Research · Leuko Labs, Inc.
Massachussetts General Hospital, Boston · Hackensack University Medical Center, Hackensack · University of Hawaii Cancer Center, Honolulu · MDA, Houston · Norton Healthcare Cancer Center, Louisville
Registry updated 2026-11-03
NCT06890884
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Trial Treatment · Phase 2 · Merck Sharp & Dohme LLC
Texas Oncology - West Texas ( Site 8008), Amarillo · Rocky Mountain Cancer Centers (RMCC) ( Site 8001), Aurora · Texas Oncology - Central/South Texas ( Site 8006), Austin · Our Lady of the Lake Physician Group-Medical Oncology ( Site 0180), Baton Rouge · Boca Raton Regional Hospital-Lynn Cancer Institute ( Site 0130), Boca Raton · Beth Israel Deaconess Medical Center ( Site 0161), Boston · Dana Farber Cancer Institute ( Site 0111), Boston · Bozeman Health Deaconess Hospital ( Site 0183), Bozeman · Erie County Medical Center ( Site 0175), Buffalo · Roswell Park Cancer Institute ( Site 0192), Buffalo · Roy and Patricia Disney Family Cancer Center - Providence Saint Joseph Medical Center ( Site 0135), Burbank · Minnesota Oncology Hematology (MNO) ( Site 8004), Burnsville · Ironwood Cancer & Research Centers ( Site 0204), Chandler · University of North Carolina Medical Center ( Site 0136), Chapel Hill · Medical University of South Carolina ( Site 0153), Charleston · Novant Health Presbyterian Medical Center ( Site 0177), Charlotte · University of Chicago Medical Center ( Site 0126), Chicago · University of Cincinnati Medical Center ( Site 0156), Cincinnati · Cleveland Clinic Main ( Site 0101), Cleveland · Fairview Hospital-Moll Cancer Center ( Site 0198), Cleveland · University Hospitals of Cleveland ( Site 0155), Cleveland · UT Southwestern Medical Center ( Site 0190), Dallas · City of Hope Comprehensive Cancer Center ( Site 0191), Duarte · Saint Elizabeth Medical Center Edgewood ( Site 0141), Edgewood · Baptist Health Hardin ( Site 0154), Elizabethtown · Palo Verde Cancer Specialists ( Site 0105), Glendale · City of Hope - Phoenix ( Site 0202), Goodyear · Colorado West Healthcare System-Grand Valley Oncology ( Site 0165), Grand Junction · Genesis Cancer and Blood Institute ( Site 0193), Hot Springs · University of Iowa-Holden Comprehensive Cancer Center ( Site 0139), Iowa City · Baptist MD Anderson Cancer Center ( Site 0176), Jacksonville · Tennessee Cancer Specialists ( Site 7004), Knoxville · Moores Cancer Center ( Site 0187), La Jolla · Baptist Health Lexington ( Site 0127), Lexington · NHO Revive Research Institute, LLC ( Site 0121), Lincoln · Norton Women's and Children's Hospital-Norton Cancer Institute - St. Matthews ( Site 0185), Louisville · SSM Health Dean Medical Group ( Site 0106), Madison · Virginia Cancer Specialists, PC ( Site 8003), Manassas · Cleveland Clinic - Hillcrest Hospital-Hillcrest Hospital Cancer Center ( Site 0199), Mayfield Heights · Mount Sinai Braman Comprehensive Cancer Center ( Site 0140), Miami Beach · Medical College of Wisconsin ( Site 0103), Milwaukee · Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0208), Mineola · Infirmary Cancer Care ( Site 0157), Mobile · Ochsner LSU Health - Monroe Medical Center, Family Medicine Clinic ( Site 0209), Monroe · Atlantic Health Morristown Medical Center ( Site 0163), Morristown · Intermountain Medical Center ( Site 0182), Murray · SCRI Oncology Partners ( Site 7002), Nashville · Medical Oncology Hematology Consultants (MOHC) ( Site 8007), Newark · Ochsner Clinic Foundation ( Site 0189), New Orleans · Laura and Isaac Perlmutter Cancer Center at NYU Langone ( Site 0108), New York · University Of Nebraska Medical Center ( Site 0110), Omaha · Mid Florida Hematology and Oncology Center ( Site 0152), Orange City · Texas Oncology - Northeast Texas ( Site 8002), Palestine · Valley Health Systems - Ridgewood Campus ( Site 0125), Paramus · Illinois Cancer Care ( Site 7005), Peoria · Temple University Hospital ( Site 0133), Philadelphia · Abramson Cancer Center and Perelman Center for Advanced Medicine ( Site 0131), Philadelphia · Providence Oncology and Hematology Clinic Westside ( Site 0179), Portland · Providence Portland Medical Center ( Site 0120), Portland · Beacon Cancer Care ( Site 0142), Post Falls · VCU Health Adult Outpatient Pavillion ( Site 0138), Richmond · Texas Oncology - San Antonio ( Site 8009), San Antonio · Alliance Cancer Specialists (ACS) ( Site 8010), Sellersville · Louisiana State University Health Sciences Shreveport ( Site 0195), Shreveport · Intermountain Healthcare - St. George ( Site 0203), St. George · SUNY Upstate Cancer Center ( Site 0178), Syracuse · The University of Texas Health Science Center at Tyler dba UT Health East Texas HOPE Cancer Center ( Site 0145), Tyler · Northwest Cancer Specialists (Compass Oncology) ( Site 8000), Vancouver · Bass Medical Group ( Site 0123), Walnut Creek · Georgetown University Medical Center ( Site 0117), Washington D.C. · Mission Blood & Cancer Care ( Site 0114), Waukee · Optum Medical Care, PC ( Site 0122), Westbury · Novant Health Forsyth Medical Center ( Site 0206), Winston-Salem · Cancer Care Associates Of York ( Site 0174), York
Registry updated 2026-11-03
NCT07691606
A Study of ARC-02 in B-cell NHL
Trial Treatment · Phase 1 · Taiho Oncology, Inc.
Levine Cancer Institute, Charlotte · Start Cala, Los Angeles · Norton Cancer Institute, Louisville · Froedtert & Medical College of Wisconsin, Milwaukee · Massey Cancer Center, Richmond · Summit Cancer Centers - North Spokane, Spokane
Registry updated 2026-11-02
NCT05952024
Study of Acalabrutinib and Rituximab in Untreated Elderly and/or Frail Patients With DLBCL
Trial Treatment · Phase 2 · AstraZeneca
Beltsville · Berkeley · Des Moines · Detroit · Jacksonville · La Jolla · Lexington · Lubbock · Olympia · Orange · Sioux Falls · Stamford · Tacoma · Towson
Registry updated 2026-10-30
NCT06395103
Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
Trial Treatment · Phase 1/2 · Merck Sharp & Dohme LLC
Children's Hospital Colorado-Center for Cancer and Blood Disorders ( Site 1016), Aurora · Dana-Farber Cancer Institute ( Site 1013), Boston · Sanford Fargo Medical Center-Roger Maris Cancer Center ( Site 1003), Fargo · Corewell Health ( Site 1001), Grand Rapids · University of Texas MD Anderson Cancer Center ( Site 1007), Houston · University of Iowa Health Care. ( Site 1017), Iowa City · Children's Mercy Hospital ( Site 1024), Kansas City · Children's Hospital Los Angeles ( Site 1006), Los Angeles · Rutgers Cancer Institute of New Jersey ( Site 1008), New Brunswick · Yale New Haven Hospital ( Site 1012), New Haven · Memorial Sloan Kettering Cancer Center ( Site 1010), New York · Children's Hospital of Philadelphia (CHOP) ( Site 1021), Philadelphia · Oregon Health and Science University ( Site 1004), Portland · Intermountain - Primary Children's Hospital ( Site 1014), Salt Lake City · Sanford Children's Hospital-Sanford Children's Specialty Clinic ( Site 1015), Sioux Falls · Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg · New York Medical College ( Site 1023), Valhalla
Registry updated 2026-10-30
NCT06500273
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Trial Treatment · Phase 2 · Allogene Therapeutics
Winship Cancer Institute, Emory University, Atlanta · Augusta University, Georgia Cancer Center, Augusta · Texas Oncology - Central South, Austin · University of Maryland Greenebaum Comprehensive Cancer Center, Baltimore · Alta Bates Summit Medical Center, Berkeley · The Center for Cancer and Blood Disorders, Bethesda · Massachusetts General Hospital, Boston · Beth Israel Deaconess Medical Center, Boston · Novant Health Cancer Institute Hematology, Charlotte · University of Virginia, Charlottesville · Rush University Medical Center, Chicago · Northwestern University Feinberg School of Medicine, Chicago · Oncology Hematology Care - Kenwood, Cincinnati · University of Cincinnati Medical Center, Cincinnati · Cleveland Clinic, Cleveland · University of Missouri - Ellis Fischel Cancer Center, Columbia · Texas Oncology - Dallas Fort Worth, Dallas · City of Hope, Duarte · Duke Blood Cancer Center, Durham · Astera Cancer Care, East Brunswick · Oncology Associates of Oregon, Eugene · Virginia Cancer Specialists, Fairfax · Fort Wayne Medical Oncology and Hematology, Fort Wayne · Banner MD Anderson Cancer Center, Gilbert · John Theurer Cancer Center, Hackensack · Genesis Cancer and Blood Institute, Hot Springs · MD Anderson Cancer Center, Houston · Indiana Blood and Marrow Transplantation, Indianapolis · IU Simon Comprehensive Cancer Center, Indianapolis · The University of Kansas Hospital, Kansas City · MidAmerica Cancer Care, Kansas City · University of Kentucky Medical Center, Lexington · Rocky Mountain Cancer Centers, Lone Tree · University of California, Los Angeles, Los Angeles · Cedars-Sinai Medical Center, Los Angeles · Norton Cancer Institute, Louisville · University of Louisville Health Brown Cancer Center, Louisville · Miami Cancer Institute at Baptist Health, Inc., Miami · University of Minnesota Medical Center, Minneapolis · Vanderbilt University Medical Center, Nashville · Medical Oncology Hematology Consultants, Newark · Rutgers Cancer Institute of New Jersey, New Brunswick · Columbia University Irving Medical Center and New York-Presbyterian Hospital, New York · Virginia Oncology Associates - Norfolk, Norfolk · Advent Health Cancer Institute, Orlando · Orlando Health Cancer Institute, Orlando · Fox Chase Cancer Center, Philadelphia · West Penn Hospital, Pittsburgh · Oregon Health and Science University, Portland · University of Rochester Medical Center, Rochester · University of California Davis Comprehensive Cancer Center, Sacramento · Intermountain Health LDS Hospital, Salt Lake City · Huntsman Cancer Institute/University of Utah, Salt Lake City · Texas Transplant Institute, San Antonio · University of California San Diego, San Diego · University of California San Francisco, San Francisco · Fred Hutchinson Cancer Center, Seattle · Swedish Cancer Institute, Seattle · Avera Cancer Institute, Sioux Falls · Oncology Hematology Associates, Springfield · Washington University School of Medicine - Siteman Cancer Center, St Louis · Moffitt Cancer Center, Tampa · Texas Oncology - Tyler, Tyler · MedStar Georgetown University Hospital, Washington D.C.
Registry updated 2026-10-30
NCT06765317
A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma
Trial Treatment · Phase 2 · Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities), Basking Ridge · Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited Protocol Activities), Commack · Hackensack Meridian Health (Data collection only), Hackensack · Memorial Sloan Kettering Westchester (All Protocol Activities), Harrison · Memorial Sloan Kettering Monmouth (Limited Protocol Activities), Middletown · Memorial Sloan Kettering Bergen (Limited Protocol Activities), Montvale · Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York · Memorial Sloan Kettering Nassau (Limited Protocol Activities), Rockville Centre
Registry updated 2026-10-30
NCT03226704
Leukapheresis for CAR or Adoptive Cell Therapy Manufacturing
Research · National Cancer Institute (NCI)
National Institutes of Health Clinical Center, Bethesda
Registry updated 2026-10-29
NCT06131801
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Research · Children's Hospital Medical Center, Cincinnati
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta · Children's Hospital Colorado, Aurora · Cincinnati Children's Hospital Medical Center, Cincinnati · Texas Children's Hospital, Houston · Children's Hospital of Wisconsin, Milwaukee · Children's Hospital of Philadelphia, Philadelphia
Registry updated 2026-10-29
NCT01137643
Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer
Research · UNC Lineberger Comprehensive Cancer Center
Lineberger Comprehensive Cancer Center at University of North Carolina, Chapel Hill, Chapel Hill
Registry updated 2026-10-28
NCT04139304
A Study of Daratumumab and Dose-Adjusted EPOCH in Plasmablastic Lymphoma
Trial Treatment · Early phase 1 · AIDS Malignancy Consortium
Johns Hopkins University/Sidney Kimmel Cancer Center, Baltimore · University of North Carolina, Chapel Hill, Chapel Hill · University of Illinois at Chicago, Chicago · The Ohio State University, Columbus · The University of Texas MD Anderson Cancer Center, Houston · University of Miami Miller School of Medicine, Miami · Memorial Sloan-Kettering Cancer Center, New York · University of Pennsylvania, Philadelphia · Huntsman Cancer Institute/University of Utah, Salt Lake City
Registry updated 2026-10-28
NCT05890352
Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
Trial Treatment · Phase 2 · SWOG Cancer Research Network
UI Health Care Mission Cancer and Blood - Ankeny Clinic, Ankeny · Trinity Health Saint Joseph Mercy Hospital Ann Arbor, Ann Arbor · ThedaCare Regional Cancer Center, Appleton · Duluth Clinic Ashland, Ashland · Tower Cancer Research Foundation, Beverly Hills · Trinity Health Medical Center - Brighton, Brighton · Trinity Health IHA Medical Group Hematology Oncology - Brighton, Brighton · Aurora Cancer Care-Southern Lakes VLCC, Burlington · Trinity Health Medical Center - Canton, Canton · Trinity Health IHA Medical Group Hematology Oncology - Canton, Canton · Mercy Hospital, Cedar Rapids · Oncology Associates at Mercy Medical Center, Cedar Rapids · Medical University of South Carolina, Charleston · Trinity Health IHA Medical Group Hematology Oncology - Chelsea Hospital, Chelsea · Chelsea Hospital, Chelsea · University of Chicago Comprehensive Cancer Center, Chicago · University of Illinois, Chicago · Siteman Cancer Center at Saint Peters Hospital, City of Saint Peters · UI Health Care Mission Cancer and Blood - West Des Moines Clinic, Clive · Siteman Cancer Center at West County Hospital, Creve Coeur · Northwest Cancer Center - Main Campus, Crown Point · Carle at The Riverfront, Danville · Essentia Health - Deer River Clinic, Deer River · UI Health Care Mission Cancer and Blood - Laurel Clinic, Des Moines · Mercy Medical Center - Des Moines, Des Moines · City of Hope Comprehensive Cancer Center, Duarte · Essentia Health Cancer Center, Duluth · Northwest Oncology LLC, Dyer · Marshfield Medical Center-EC Cancer Center, Eau Claire · Carle Physician Group-Effingham, Effingham · Genesys Hurley Cancer Institute, Flint · Hurley Medical Center, Flint · Genesee Hematology Oncology PC, Flint · Cancer Hematology Centers - Flint, Flint · Holy Cross Hospital, Fort Lauderdale · Aurora Health Care Germantown Health Center, Germantown · Aurora Cancer Care-Grafton, Grafton · Aurora BayCare Medical Center, Green Bay · Essentia Health Hibbing Clinic, Hibbing · Saint Mary Medical Center, Hobart · Northwest Cancer Center - Hobart, Hobart · Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston · Ben Taub General Hospital, Houston · City of Hope Seacliff, Huntington Beach · Saint Catherine Hospital, Indianapolis · University of Mississippi Medical Center, Jackson · Aurora Cancer Care-Kenosha South, Kenosha · Gundersen Lutheran Medical Center, La Crosse · City of Hope Antelope Valley, Lancaster · University of Michigan Health - Sparrow Lansing, Lansing · Trinity Health Saint Mary Mercy Livonia Hospital, Livonia · City of Hope at Long Beach Elm, Long Beach · Cedars-Sinai Medical Center, Los Angeles · Aurora Bay Area Medical Group-Marinette, Marinette · Marshfield Medical Center-Marshfield, Marshfield · Carle Physician Group-Mattoon/Charleston, Mattoon · Mount Sinai Medical Center, Miami Beach · Aurora Cancer Care-Milwaukee, Milwaukee · Aurora Saint Luke's Medical Center, Milwaukee · Aurora Sinai Medical Center, Milwaukee · Marshfield Medical Center - Minocqua, Minocqua · Women's Diagnostic Center - Munster, Munster · The Community Hospital, Munster · Providence Newberg Medical Center, Newberg · UC Comprehensive Cancer Center at Silver Cross, New Lenox · City of Hope Newport Beach, Newport Beach · NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York · University of Oklahoma Health Sciences Center, Oklahoma City · Providence Willamette Falls Medical Center, Oregon City · University of Chicago Medicine-Orland Park, Orland Park · Vince Lombardi Cancer Clinic - Oshkosh, Oshkosh · Trinity Health Saint Joseph Mercy Oakland Hospital, Pontiac · Providence Portland Medical Center, Portland · Providence Saint Vincent Medical Center, Portland · Aurora Cancer Care-Racine, Racine · Marshfield Medical Center-Rice Lake, Rice Lake · VCU Massey Comprehensive Cancer Center, Richmond · VCU Massey Cancer Center at Stony Point, Richmond · University of Rochester, Rochester · Huntsman Cancer Institute/University of Utah, Salt Lake City · University of Texas Health Science Center at San Antonio, San Antonio · Essentia Health Sandstone, Sandstone · Vince Lombardi Cancer Clinic-Sheboygan, Sheboygan · Memorial Hospital East, Shiloh · City of Hope South Pasadena, South Pasadena · Marshfield Medical Center-River Region at Stevens Point, Stevens Point · Washington University School of Medicine, St Louis · Siteman Cancer Center at Christian Hospital, St Louis · Siteman Cancer Center-South County, St Louis · Aurora Medical Center in Summit, Summit · City of Hope South Bay, Torrance · University of Arizona Cancer Center-North Campus, Tucson · Banner University Medical Center - Tucson, Tucson · Vince Lombardi Cancer Clinic-Two Rivers, Two Rivers · City of Hope Upland, Upland · Carle Cancer Center, Urbana · Northwest Cancer Center - Valparaiso, Valparaiso · Essentia Health Virginia Clinic, Virginia · Aurora Cancer Care-Milwaukee West, Wauwatosa · Wilmot Cancer Institute at Webster, Webster · Aurora West Allis Medical Center, West Allis · Marshfield Medical Center - Weston, Weston · Trinity Health IHA Medical Group Hematology Oncology Ann Arbor Campus, Ypsilanti · Huron Gastroenterology PC, Ypsilanti
Registry updated 2026-10-28
NCT04002947
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
Trial Treatment · Phase 2 · National Cancer Institute (NCI)
National Institutes of Health Clinical Center, Bethesda
Registry updated 2026-10-26
NCT04545762
Anti-CD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Non-Hodgkin Lymphoma
Trial Treatment · Phase 1 · C. Babis Andreadis
University of California San Francisco, San Francisco
Registry updated 2026-10-26
NCT06015880
Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Trial Treatment · Phase 1 · National Cancer Institute (NCI)
University of Virginia Cancer Center, Charlottesville · Northwestern University, Chicago · Case Western Reserve University, Cleveland · City of Hope Comprehensive Cancer Center, Duarte · University of Oklahoma Health Sciences Center, Oklahoma City · University of California Davis Comprehensive Cancer Center, Sacramento · Moffitt Cancer Center, Tampa · Wake Forest University Health Sciences, Winston-Salem
Registry updated 2026-10-26
NCT06533579
Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
Trial Treatment · Phase 1/2 · Vironexis Biotherapeutics Inc.
University of North Carolina at Chapel Hill/ University of North Carolina Medical Center, Chapel Hill · The Ohio State University -Wexner Medical Center, Columbus · Colorado Blood Cancer Institute, Denver · City of Hope, Duarte · University of Texas - MD Anderson Cancer Center, Houston · Mayo Clinic, Clinical Trials Referral Office, Jacksonville · Valkyrie Clinical Trials, Los Angeles · TriStar BMT, Nashville · Oregon Health Science University, Portland · Mayo Clinic, Clinical Trials Referral Office, Rochester · New York Medical College, Valhalla
Registry updated 2026-10-26
NCT07725406
Low-Dose TBI Plus CAR T-Cell Therapy for Relapsed/Refractory DLBCL and Multiple Myeloma
Trial Treatment · Phase 1 · Weill Medical College of Cornell University
Weill Cornell Medicine/NewYork-Presbyterian Hospital, New York
Registry updated 2026-10-26
All Diffuse large B-cell lymphoma trials and the map
This page is not medical advice. Talk to your doctor before contacting a trial.